Alexander Hodge1, Dinushka Lourensz1, Vijesh Vaghjiani2, Huyen Nguyen1, Jorge Tchongue1, Bo Wang3, Padma Murthi4, William Sievert1, Ursula Manuelpillai5. 1. Centre for Inflammatory Diseases, Monash University, Melbourne, Australia; Gastroenterology and Hepatology Unit, Monash Health, Melbourne, Australia. 2. Centre for Genetic Diseases, Monash Institute of Medical Research, Monash University, Melbourne, Australia. 3. Department of Anatomy and Developmental Biology, Monash University, Melbourne, Australia. 4. Department of Obstetrics & Gynaecology, University of Melbourne & Pregnancy Research Centre, Department of Perinatal Medicine, Royal Women's Hospital, Melbourne, Australia. 5. Centre for Genetic Diseases, Monash Institute of Medical Research, Monash University, Melbourne, Australia. Electronic address: ursula.manuelpillai@monash.edu.
Abstract
BACKGROUND: Intravenous infusion of human amniotic epithelial cells (hAECs) has been shown to ameliorate hepatic fibrosis in murine models. Hepatic stellate cells (HSCs) are the principal collagen-secreting cells in the liver. The aim of this study was to investigate whether factors secreted by hAECs and present in hAEC-conditioned medium (CM) have anti-fibrotic effects on activated human HSCs. METHODS: Human AECs were isolated from the placenta and cultured. Human hepatic stellate cells were exposed to hAEC CM to determine potential anti-fibrotic effects. RESULTS: HSCs treated for 48 h with hAEC CM displayed a significant reduction in the expression of the myofibroblast markers α-smooth muscle actin and platelet-derived growth factor. Expression of the pro-fibrotic cytokine transforming growth factor-β1 (TGF-β1) and intracellular collagen were reduced by 45% and 46%, respectively. Human AEC CM induced HSC apoptosis in 11.8% of treated cells and reduced HSC proliferation. Soluble human leukocyte antigen-G1, a hAEC-derived factor, significantly decreased TGF-β1 and collagen production in activated HSCs, although the effect on collagen production was less than that of hAEC CM. The reduction in collagen and TGF-B1 could not be attributed to PGE2, relaxin, IL-10, TGF-B3, FasL or TRAIL. CONCLUSIONS: Human AEC CM treatment suppresses markers of activation, proliferation and fibrosis in human HSCs as well as inducing apoptosis and reducing proliferation. Human AEC CM treatment may be effective in ameliorating liver fibrosis and warrants further study.
BACKGROUND: Intravenous infusion of human amniotic epithelial cells (hAECs) has been shown to ameliorate hepatic fibrosis in murine models. Hepatic stellate cells (HSCs) are the principal collagen-secreting cells in the liver. The aim of this study was to investigate whether factors secreted by hAECs and present in hAEC-conditioned medium (CM) have anti-fibrotic effects on activated human HSCs. METHODS:Human AECs were isolated from the placenta and cultured. Human hepatic stellate cells were exposed to hAEC CM to determine potential anti-fibrotic effects. RESULTS: HSCs treated for 48 h with hAEC CM displayed a significant reduction in the expression of the myofibroblast markers α-smooth muscle actin and platelet-derived growth factor. Expression of the pro-fibrotic cytokine transforming growth factor-β1 (TGF-β1) and intracellular collagen were reduced by 45% and 46%, respectively. Human AEC CM induced HSC apoptosis in 11.8% of treated cells and reduced HSC proliferation. Soluble human leukocyte antigen-G1, a hAEC-derived factor, significantly decreased TGF-β1 and collagen production in activated HSCs, although the effect on collagen production was less than that of hAEC CM. The reduction in collagen and TGF-B1 could not be attributed to PGE2, relaxin, IL-10, TGF-B3, FasL or TRAIL. CONCLUSIONS:Human AEC CM treatment suppresses markers of activation, proliferation and fibrosis in human HSCs as well as inducing apoptosis and reducing proliferation. Human AEC CM treatment may be effective in ameliorating liver fibrosis and warrants further study.
Authors: Jean L Tan; Siow T Chan; Camden Y Lo; James A Deane; Courtney A McDonald; Claude Ca Bernard; Euan M Wallace; Rebecca Lim Journal: Stem Cell Res Ther Date: 2015-01-29 Impact factor: 6.832
Authors: Jean L Tan; Sin N Lau; Bryan Leaw; Hong P T Nguyen; Lois A Salamonsen; Mohamed I Saad; Siow T Chan; Dandan Zhu; Mirja Krause; Carla Kim; William Sievert; Euan M Wallace; Rebecca Lim Journal: Stem Cells Transl Med Date: 2018-01-03 Impact factor: 6.940
Authors: William Sievert; Rebecca Lim; Mihiri Goonetilleke; Nathan Kuk; Jeanne Correia; Alex Hodge; Gregory Moore; Michael P Gantier; George Yeoh Journal: Stem Cell Res Ther Date: 2021-07-28 Impact factor: 6.832
Authors: Antonia Alcaraz; Anna Mrowiec; Carmen Luisa Insausti; Ángel Bernabé-García; Eva María García-Vizcaíno; María Concepción López-Martínez; Asunción Monfort; Ander Izeta; José María Moraleda; Gregorio Castellanos; Francisco José Nicolás Journal: PLoS One Date: 2015-08-18 Impact factor: 3.240
Authors: Majid Alhomrani; Jeanne Correia; Marcus Zavou; Bryan Leaw; Nathan Kuk; Rong Xu; Mohamed I Saad; Alexander Hodge; David W Greening; Rebecca Lim; William Sievert Journal: Front Pharmacol Date: 2017-10-24 Impact factor: 5.810